ABBV vs ARRY · P/E 81, rev $61.16B vs rev $915.8M
AbbVie Inc (ABBV) versus Array Technologies Inc (ARRY) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Array Technologies Inc (ARRY) is a solar company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ARRY revenue for 2024-12-31 was $915.8M. Net income was -$240.4M. Revenue was down 41.9% from 2023-12-31 to 2024-12-31. ARRY currently screens at market cap $1.42B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ARRY currently screens at market cap $1.42B.
Not investment advice. Open the ABBV and ARRY stock pages for the full models.
Not investment advice.